JS

Japji Singh

Active Director Director DIN 10430505
DIN 10430505 First appointment Dec 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Japji Singh

Data last updated:

Japji Singh is a Director at Natlabs Healthcare Private Limited (since 2023). Natlabs Healthcare Private Limited reported revenue of ₹4.36 Cr (FY 2025).

DIN 10430505
Primary Designation Director
First Appointment 18 Dec 2023
Oldest Company Age 2 yrs
Largest company Natlabs Healthcare Private Limited · ₹4.36 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Natlabs Healthcare Private Limited U86905PB2023PTC060253
Director18 Dec 20232023₹4.36 Cr (FY 2025)Active

Board colleagues of Japji Singh

NameDINCompanyDesignation
Harvinder Singh Makkar10430504Natlabs Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Natlabs Healthcare Private Limited
Premium access

Shareholding and investment profile for Japji Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Japji Singh

Japji Singh currently holds 1 directorship: Natlabs Healthcare Private Limited (Director, since 18 Dec 2023, revenue ₹4.36 Cr (FY 2025)).

Japji Singh was first appointed on 18 Dec 2023 as Director at Natlabs Healthcare Private Limited.

The current boards of Japji Singh's companies include Harvinder Singh Makkar (Natlabs Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available